APP204349

Application overview Plus
Application code:
APP204349
Application type:
GM Development
Applicant:
Malaghan Institute of Medical Research
Applicant postal address:
PO Box 7060, Newtown, Wellington, 6242, New Zealand
Application state:
Decided
Application decision:
Approved with Controls
Application purpose:
To develop genetically modified human cells for the packaging and testing of 3rd generation self-inactivating lentiviral vectors, to be used to genetically modify human T cells for the expression of genes that regulate the activity of human immune cells.
Decision notified date:
20 December 2021
IBSC Reference:
 
Substances or organisms in application Plus
Name:
Human commercial somatic cell lines and primary immune cells
Decision:
Approved with Controls
Synonyms:
 
Approval number:
GMD102750
Trade names:
Homo sapiens (animal, mammal, GM, development, cell line, human)
Approval status:
 
Approval expiry date:
 
Application superceded by: